These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2829751)

  • 1. Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE) and 5,12-dihydroxyeicosatetraenoic acid (leukotriene B4) in psoriasis and normal human skin.
    Dowd PM; Black AK; Woollard PW; Greaves MW
    Arch Dermatol Res; 1987; 279(7):427-34. PubMed ID: 2829751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiinflammatory effects of second-generation leukotriene B4 receptor antagonist, SC-53228: impact upon leukotriene B4- and 12(R)-HETE-mediated events.
    Fretland DJ; Anglin CP; Bremer M; Isakson P; Widomski DL; Paulson SK; Docter SH; Djuric SW; Penning TD; Yu S
    Inflammation; 1995 Apr; 19(2):193-205. PubMed ID: 7601505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15-hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits the LTB4-induced skin response.
    Ternowitz T; Andersen PH; Bjerring P; Fogh K; Schröder JM; Kragballe K
    Arch Dermatol Res; 1989; 281(6):401-5. PubMed ID: 2556975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SC-41930 inhibits neutrophil infiltration of the cavine dermis induced by 12(R)-hydroxyeicosatetraenoic acid.
    Fretland DJ; Widomski DL; Shone RL; Penning TD; Miyashiro JM; Djuric SW
    Prostaglandins Leukot Essent Fatty Acids; 1989 Dec; 38(3):169-72. PubMed ID: 2560200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of psoriatic lesions to multiple applications of leukotriene B4 and 12-HETE.
    Norris PG; Schofield O; Dowd PM; Greaves MW
    Dermatologica; 1987; 174(5):219-23. PubMed ID: 3034690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE).
    Dowd PM; Kobza Black A; Woollard PM; Camp RD; Greaves MW
    J Invest Dermatol; 1985 Jun; 84(6):537-41. PubMed ID: 3998504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting in vitro lymphocyte chemotactic activity of the hydroxyl enantiomers of 12-hydroxy-5,8,10,14-eicosatetraenoic acid.
    Bacon KB; Camp RD; Cunningham FM; Woollard PM
    Br J Pharmacol; 1988 Nov; 95(3):966-74. PubMed ID: 2850067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 12(R)-hydroxy-5,8,10,14-eicosatetraenoic acid is a chemoattractant for human polymorphonuclear leucocytes in vitro.
    Cunningham FM; Woollard PM
    Prostaglandins; 1987 Jul; 34(1):71-8. PubMed ID: 3317516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid is a more potent neutrophil chemoattractant than the 12(R) epimer in the rat cornea.
    Wiggins RE; Jafri MS; Proia AD
    Prostaglandins; 1990 Aug; 40(2):131-41. PubMed ID: 2171040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the proinflammatory effects of 12(R)- and 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid in human skin.
    Wollard PM; Cunnigham FM; Murphy GM; Camp RD; Derm FF; Greaves MW
    Prostaglandins; 1989 Oct; 38(4):465-71. PubMed ID: 2813813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemokinetic response of psoriatic and normal polymorphonuclear leukocytes to arachidonic acid lipoxygenase products.
    Cunningham FM; Wong E; Woollard PM; Greaves MW
    Arch Dermatol Res; 1986; 278(4):270-3. PubMed ID: 3017241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-trans-leukotriene B4 is a neutrophil chemotaxin in the guinea pig dermis.
    Fretland DJ; Widomski DL; Anglin CP; Walsh RE; Levin S; Gaginella TS
    J Leukoc Biol; 1991 Mar; 49(3):283-8. PubMed ID: 1847716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro synthesis of 12-hydroxy-eicosatetraenoic acid is increased in uninvolved psoriatic epidermis.
    Kragballe K; Desjarlais L; Duell EA; Voorhees JJ
    J Invest Dermatol; 1986 Jul; 87(1):47-52. PubMed ID: 3088130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fifteen-S-hydroxyeicosatetraenoic acid (15-S-HETE) specifically antagonizes the chemotactic action and glomerular synthesis of leukotriene B4 in the rat.
    Fischer DB; Christman JW; Badr KF
    Kidney Int; 1992 May; 41(5):1155-60. PubMed ID: 1319518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of human neutrophils by 5-oxo-6,8,11,14-eicosatetraenoic acid by a mechanism independent of the leukotriene B4 receptor.
    Powell WS; Gravel S; MacLeod RJ; Mills E; Hashefi M
    J Biol Chem; 1993 May; 268(13):9280-6. PubMed ID: 8387490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 15-Hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits LTB4-induced chemotaxis of human neutrophils.
    Ternowitz T; Fogh K; Kragballe K
    Skin Pharmacol; 1988; 1(2):93-9. PubMed ID: 2856182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SC-41930, a leukotriene B4 receptor antagonist, inhibits 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) binding to epidermal cells.
    Kemény L; Ruzicka T
    Agents Actions; 1991 Mar; 32(3-4):339-42. PubMed ID: 1650525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosynthesis of lipoxygenase products by enzyme preparations from normal and psoriatic skin.
    Ziboh VA; Casebolt TL; Marcelo CL; Voorhees JJ
    J Invest Dermatol; 1984 Dec; 83(6):426-30. PubMed ID: 6094672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of neutrophil chemotaxis by leukotriene B4 and 5-hydroxyeicosatetraenoic acid in chronic inflammatory bowel disease.
    Nielsen OH; Elmgreen J
    Scand J Clin Lab Invest; 1987 Oct; 47(6):605-11. PubMed ID: 2823370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukotriene B4 fails to induce penetration of polymorphonuclear leukocytes into psoriatic lesions.
    Lammers AM; van de Kerkhof PC
    Br J Dermatol; 1987 Nov; 117(5):541-4. PubMed ID: 2825753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.